EN PL

News

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 03, 2017 on guidelines for the naming of medicinal products for human use

10.02.2017
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 03, 2017 on guidelines for the naming of medicinal ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of October 13, 2016 on verification and additions EAN / GTIN for veterinary medicinal products

17.11.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of October 13, 2016 on verification and additions EAN / GTIN ...

URPL: Information of General Director of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of August 23, 2016 on the procedures for the access to the file of proceedings.

08.09.2016
This document is announcement of General Director of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of August 23, 2016 on the procedures for the access to ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 13, 2015 on the implementation of the Ordinance delegated Regulation (EU) 2016/161 of October 2, 2015 supplementing Directi

19.04.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of April 13, 2015 on the implementation of the Ordinance ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 15, 2015 on the abolition of the requirement of payment of fees for the notification referred to in Article 58 paragraph 3

04.04.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 15, 2015 on the abolition of the requirement of ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 30, 2015 on the the fulfillment by responsible entities from the obligation referred to in Article 24 paragraph 1 point 4 l

04.04.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 30, 2015 on the the fulfillment by responsible ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts will provide in the context of the global response to the growing epidemi

17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on the support which European experts ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR used in the study ROCKET

17.02.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 16, 2015 on on the malfunctioning analyzer INR ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss of news tips published in the European Commission document,, Manual of D

29.01.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of January 12, 2015 concerning the consequences of the loss ...

URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 28, 2015 concerning the new recommendations aimed at minimizing the risk of a rare infection PML, and one of the types

11.01.2016
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of December 28, 2015 concerning the new recommendations aimed ...